_Meet our ongoing investments

Our mission is simple – provide our investors with access to the most promising and impactful life sciences technologies.

We focus mostly on early-stage companies developing novel therapies in Europe and the US. Within therapeutics, we remain agnostic in terms of indication and modality, but value highly differentiated companies targeting clear unmet needs.